MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
0.9677
+0.0028
+0.29%
After Hours: 0.9677 0 0.00% 19:34 08/14 EDT
OPEN
0.9741
PREV CLOSE
0.9649
HIGH
0.9998
LOW
0.9600
VOLUME
574.64K
TURNOVER
--
52 WEEK HIGH
1.629
52 WEEK LOW
0.8605
MARKET CAP
196.68M
P/E (TTM)
-2.0633
1D
5D
1M
3M
1Y
5Y
1D
Lucid Diagnostics (LUCD) Receives a Buy from Maxim Group
TipRanks · 14h ago
Press Release: PAVmed Provides Business Update -2-
Dow Jones · 15h ago
Analysts’ Top Healthcare Picks: Lucid Diagnostics (LUCD), Takeda Pharmaceutical Company (TAK)
TipRanks · 1d ago
Lucid Diagnostics Q2 2026 Earnings Call: Complete Transcript
Benzinga · 1d ago
Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates
NASDAQ · 1d ago
Lucid Diagnostics Reports Q2 Growth Ahead of Medicare Decision
TipRanks · 1d ago
Lucid Diagnostics Non-GAAP EPS of -$0.06 misses by $0.01, revenue of $1.47M misses by $0.46M
Seeking Alpha · 1d ago
Press Release: Lucid Diagnostics Provides -2-
Dow Jones · 1d ago
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company's products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. The Company is a subsidiary of PAVmed Inc.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.